MétaCan
Menu
Back to cohort
Record W1992549147 · doi:10.1016/j.ymthe.2006.08.1193

1091. Successful Induction of Immune Tolerance to Canine Factor VIII after Lentiviral-Mediated Gene Therapy in Neonatal Hemophilia A Mice

2006· article· en· W1992549147 on OpenAlexaff
Hideto Matsui, Masaru Shibata, Brian D. Brown, Andrea Labelle, Carol Hegadorn, C. Webb Andrews, Marinee Chuah, Thierry VandenDriessche, Carol H. Miao, Christine Hough, David Lillicrap

Bibliographic record

VenueMolecular Therapy · 2006
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicVirus-based gene therapy research
Canadian institutionsQueen's University
Fundersnot available
KeywordsGenetic enhancementMedicineAntibodyNeutralizing antibodyTransgeneTiterImmune toleranceFactor IXImmunologyViral vectorImmune systemVirologyRecombinant DNAPharmacologyInternal medicineBiologyGene

Abstract

fetched live from OpenAlex

The development of neutralizing antibodies (inhibitors) directed against Factor VIII (FVIII) is currently the most significant complication associated with FVIII replacement therapy in hemophilia A patients and presents a considerable obstacle to successful gene therapy strategies. Induction of immunological tolerance (ITI) to FVIII involves frequent intravenous infusions of FVIII according to various therapeutic regimens, and has been successful in many inhibitor-positive patients. However, ITI is not successful in all patients and it requires frequent intravenous access and is very expensive. Alternative methods of inducing tolerance to the FVIII protein may prove beneficial especially if this can be achieved prior to inhibitor development. With a view to utilizing the potential of neonatal immune-privilege, we administered canine-FVIII expressing lentiviral vectors prior to FVIII protein challenge. The lentiviral vector, hAAT-cFVIII-LV, contained a B domain-deleted canine FVIII transgene under the control of a liver specific promoter. 1x108 Transducing Units (TU)/mouse were administrated to 0-1 day old Balb/c hemophilia A neonates either intravenously (IV), intraperitoneally (IP) or subcutaneously (SC). Neutralizing anti- canine FVIII antibodies developed in all mice treated with IP or SC injection, In contrast, FVIII activity (range <10-1586.7mU/mL) was detected for greater than 3 months in 8/13 mice treated intravenously and all mice failed to develop high-titer neutralizing anti-FVIII antibodies. To evaluate long-term tolerance induction following this protocol, 3 of these mice were challenged, 52 weeks post-hAAT- cFVIII-LV treatment, with four intravenous infusions of 0.2ug recombinant canine FVIII (rcFVIII) protein (80U/kg). Splenocytes were isolated, cultured and in vitro cytokine production and T cell proliferation, was assessed. Treated mice injected with rcFVIII remained inhibitor negative and this tolerance was accompanied by increased in vitro T cell production of IL-10 in parallel with decreased production of IL-6 and IFN-γ in vitro. The splenocytes from these tolerant mice are capable of transferring tolerance to naïve recipient hemophilia A Balb/c mice indicating that the mechanism underlying this phenomenon likely involves regulatory T lymphocytes.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.014
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.009
GPT teacher head0.255
Teacher spread0.246 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2006
Admission routes1
Has abstractyes

Explore more

Same venueMolecular TherapySame topicVirus-based gene therapy researchFrench-language works237,207